Furthermore, to further enhance the targeting efficiency, in an experiment for targeting VEGF-overexpressed cancer cells, Chen et al. constructed a doxorubicin (DOX)-loaded Zr4+-MOF with dual aptamer, VEGF aptamer, and AS1411 aptamer. This evidence concerns the gene VEGFA and cancer.